The global rare neurological disease treatment market share analysis is experiencing a significant upsurge, fueled by groundbreaking advances in orphan drug development, biologics, and targeted therapies. With improved diagnostic capabilities and a rising prevalence of such disorders, the market is expected to grow at an impressive CAGR of 7.4%, reaching a valuation of USD 40,671.5 …